Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Articles
BioCentury
|
Oct 8, 2007
Company News
GammaCan, DCI Biologicals Inc., Life Therapeutics deal
...not disclosed. GammaCan International Inc. (GCAN), Kiryat Ono, Israel DCI Biologicals Inc. , Northport, N.Y.
Life Therapeutics
...
Read More
BioCentury
|
Aug 13, 2007
Clinical News
VitiGam regulatory update
...early next year. In 2006, GCAN signed a term sheet to co-develop the agent with
Life Therapeutics Ltd.
...
Read More
BioCentury
|
Aug 28, 2006
Company News
GammaCan International, Life Therapeutics deal
...profits. GCAN's first-generation GCAN101 is in Phase II testing. GammaCan International (GCAN), Kiryat Ono, Israel
Life Therapeutics
...
Read More
BioCentury
|
May 16, 2005
Finance
Taking the ADR route
...Australia BNY 11/12/04 Senetek OTC SNTKY U.K. BNY 11/10/04 Alchemia OTC AEMAY Australia BNY 11/3/04
Life Therapeutics
...
Read More
BioCentury
|
May 9, 2005
Company News
Corautus management update
...Gene/Cell therapy, Cardiovascular Hired: Michael Steele as VP of business development, formerly corporate VP at
Life Therapeutics Ltd.
WIR...
Read More
Items per page:
10
1 - 5 of 5
BioCentury
|
Oct 8, 2007
Company News
GammaCan, DCI Biologicals Inc., Life Therapeutics deal
...not disclosed. GammaCan International Inc. (GCAN), Kiryat Ono, Israel DCI Biologicals Inc. , Northport, N.Y.
Life Therapeutics
...
Read More
BioCentury
|
Aug 13, 2007
Clinical News
VitiGam regulatory update
...early next year. In 2006, GCAN signed a term sheet to co-develop the agent with
Life Therapeutics Ltd.
...
Read More
BioCentury
|
Aug 28, 2006
Company News
GammaCan International, Life Therapeutics deal
...profits. GCAN's first-generation GCAN101 is in Phase II testing. GammaCan International (GCAN), Kiryat Ono, Israel
Life Therapeutics
...
Read More
BioCentury
|
May 16, 2005
Finance
Taking the ADR route
...Australia BNY 11/12/04 Senetek OTC SNTKY U.K. BNY 11/10/04 Alchemia OTC AEMAY Australia BNY 11/3/04
Life Therapeutics
...
Read More
BioCentury
|
May 9, 2005
Company News
Corautus management update
...Gene/Cell therapy, Cardiovascular Hired: Michael Steele as VP of business development, formerly corporate VP at
Life Therapeutics Ltd.
WIR...
Read More
Items per page:
10
1 - 5 of 5
Previous page
Next page